These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12610048)

  • 1. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience.
    Eberly LE; Cohen JD; Prineas R; Yang L;
    Diabetes Care; 2003 Mar; 26(3):848-54. PubMed ID: 12610048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.
    Barzilay JI; Davis BR; Pressel SL; Cutler JA; Einhorn PT; Black HR; Cushman WC; Ford CE; Margolis KL; Moloo J; Oparil S; Piller LB; Simmons DL; Sweeney ME; Whelton PK; Wong ND; Wright JT;
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):153-62. PubMed ID: 22396585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus.
    Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN
    Circulation; 2008 May; 117(21):2734-42. PubMed ID: 18490521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
    Echouffo-Tcheugui JB; Zhao S; Brock G; Matsouaka RA; Kline D; Joseph JJ
    Diabetes Care; 2019 Mar; 42(3):486-493. PubMed ID: 30659073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study).
    Simons LA; Simons J; Friedlander Y; McCallum J
    Am J Cardiol; 2008 Oct; 102(7):831-4. PubMed ID: 18805106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic population mortality and cardiovascular risk attributable to hypertension: a decade follow-up from the Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Mohebi R; Ghanbarian A; Eskandari F; Azizi F
    Blood Press; 2013 Oct; 22(5):317-24. PubMed ID: 23458066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study.
    Fox CS; Sullivan L; D'Agostino RB; Wilson PW;
    Diabetes Care; 2004 Mar; 27(3):704-8. PubMed ID: 14988289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality.
    Bancks MP; Carson AP; Lewis CE; Gunderson EP; Reis JP; Schreiner PJ; Yano Y; Carnethon MR
    Diabetologia; 2019 Aug; 62(8):1366-1374. PubMed ID: 31115643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of smoking status on 9.3 years incidence of cardiovascular and all-cause mortality among Iranian men.
    Ehteshami-Afshar S; Momenan A; Hajshekholeslami F; Azizi F; Hadaegh F
    Ann Hum Biol; 2014; 41(3):249-54. PubMed ID: 24215537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
    DECODE Study Group, European Diabetes Epidemiology Group
    Diabetes Care; 2003 Mar; 26(3):688-96. PubMed ID: 12610023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary Artery Calcification (CAC) and Post-Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen-Alone Trial.
    Poornima IG; Mackey RH; Allison MA; Manson JE; Carr JJ; LaMonte MJ; Chang Y; Kuller LH;
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality.
    Daviglus ML; Stamler J; Pirzada A; Yan LL; Garside DB; Liu K; Wang R; Dyer AR; Lloyd-Jones DM; Greenland P
    JAMA; 2004 Oct; 292(13):1588-92. PubMed ID: 15467061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80.
    Kadowaki S; Okamura T; Hozawa A; Kadowaki T; Kadota A; Murakami Y; Nakamura K; Saitoh S; Nakamura Y; Hayakawa T; Kita Y; Okayama A; Ueshima H;
    Diabetologia; 2008 Apr; 51(4):575-82. PubMed ID: 18197396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial.
    Eberly LE; Neaton JD; Thomas AJ; Yu D;
    Clin Trials; 2004; 1(2):148-61. PubMed ID: 16281887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.
    Vaccaro O; Eberly LE; Neaton JD; Yang L; Riccardi G; Stamler J;
    Arch Intern Med; 2004 Jul; 164(13):1438-43. PubMed ID: 15249353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
    Schindhelm RK; Dekker JM; Nijpels G; Bouter LM; Stehouwer CD; Heine RJ; Diamant M
    Atherosclerosis; 2007 Apr; 191(2):391-6. PubMed ID: 16682043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial.
    Gump BB; Matthews KA; Eberly LE; Chang YF;
    Stroke; 2005 Jan; 36(1):98-102. PubMed ID: 15569872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.
    Stamler J; Neaton JD; Cohen JD; Cutler J; Eberly L; Grandits G; Kuller LH; Ockene J; Prineas R;
    J Am Heart Assoc; 2012 Oct; 1(5):e003640. PubMed ID: 23316301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.